Turning Negative on Baozun: Software Upgrade Delayed; E-Commerce Premiumization Slows
Baozun Inc. (BZUN US) was our top long idea for the past 8 months with a price target of $45. At its current $55 per share, the stock price in...
419 Views
Pinduoduo (PDD US): Alibaba’s Latest Attempt to Disrupt Reinforces the Buy Case
As we rightly predicted in Pinduoduo (PDD US): Keep Calm and Ride the Storm, the media frenzy and some sensationalist analyst commentary on...
432 Views
Meituan Dianping – Peak Value Is Estimated @ US$ 7.50/Share
Meituan Dianping (MEITUAN CH) is coming to the market at a difficult time. A slowing Chinese economy, a weaker currency and the threat of an...
395 Views
Last Week in GER Research: Ascletis Pharma, China Tower, Pinduoduo, Beigene and CNFinance
Below is a recap of the key IPO research produced by the Global Equity Research team. This week we highlight our sensitivity analysis for Ascletis...
802 Views
Pinduoduo (PDD US): Keep Calm and Ride the Storm
After a stonking IPO, Pinduoduo (PDD US) has faced a barrage of negative press reports rightly highlighting the number of counterfeit products...
562 Views